BioCentury
ARTICLE | Clinical News

AIC499: Ph I started

January 25, 2017 2:43 AM UTC

AiCuris began a single-blind, placebo-controlled, Austrian Phase I trial to evaluate single and multiple ascending doses of IV AIC499 in 48 healthy volunteers. The trial is being supported by the COMB...